As of June 2026, 2 paid clinical trials are recruiting for Gynecologic oncology in Longmont, Colorado. Gynecologic oncology studies test PARP inhibitors, antibody-drug conjugates, maintenance therapies, and immune checkpoint inhibitors for ovarian, endometrial, cervical, and other gyn cancers. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Longmont has approximately 63 recruiting research studies across a wide range of therapeutic areas. Colorado hosts the University of Colorado Anschutz Medical Campus, National Jewish Health, and Children's Hospital Colorado, with strong programs in pulmonology, oncology, and cardiovascular research.
Researchers run research studies in Longmont, CO at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Longmont United Hospital | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 41 |
| Rocky Mountain Cancer Centers-Longmont | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Chronic Lymphocytic Leukemia | 28 |
| Rocky Mountain Cancer Centers, LLP | Breast Cancer, Advanced Breast Cancer, Breast Neoplasms | 4 |
| Advanced Vision Research Institute | Age Related Cataracts, Geographic Atrophy Secondary to Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration | 3 |
| UCHealth Longs Peak Medical Center | Multiple Myeloma | 2 |
| Advance Vision Research Institute | Neurotrophic Keratopathy | 1 |
| Advanced Neurosciences Research LLC | Generalized Myasthenia Gravis | 1 |
| Advanced Vision Research Institute /ID# 256380 | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Advanced Vision Surgery Center /ID# 264208 | Neovascular Age-related Macular Degeneration | 1 |
| Eye care Center of Northern Colorado doing business as Advanced Vision Research Institute | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Local Institution - 007-872-G | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Longs Peak Hospital | Multiple Myeloma | 1 |
| Rocky Mountain Cancer Center - Longmont | Metastatic Breast Cancer | 1 |
| Rocky Mountain Cancer Centers LLP | Breast Cancer | 1 |
| Tekton Research, LLC | Influenza | 1 |
| UCHealth Family Medicine - Longmont | Obesity | 1 |
| UCHealth Internal Medicine - Longmont | Obesity | 1 |
| UCHealth Longmont Clinic | Obesity | 1 |
| UCHealth Longs Peak Hospital | Multiple Myeloma | 1 |
Recruiting trials in Longmont grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Colorado are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Colorado trials are additionally subject to the Colorado Privacy Act (CPA), which adds consumer data-protection requirements to federal baseline standards.
Hipa.ai aggregates every recruiting study in Longmont from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 63 recruiting clinical trials in Longmont, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Longmont compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Longmont include Breast Cancer (5), Malignant Solid Neoplasm (3), Stage IIIB Lung Cancer AJCC v8 (3), Anatomic Stage I Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Longmont on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Longmont include Longmont United Hospital, Rocky Mountain Cancer Centers-Longmont, Rocky Mountain Cancer Centers, LLP, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Longmont are Cancer & tumors (45), Eye & vision (5), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.